Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study
2010 ◽
Vol 88
(1)
◽
pp. 12-19
◽
Keyword(s):
2006 ◽
Vol 22
(9)
◽
pp. 1643-1649
◽
Keyword(s):
2018 ◽
Vol 27
(12)
◽
pp. 1175-1180
◽
2005 ◽
Vol 140
(2)
◽
pp. 242.e1-242.e11
◽
Keyword(s):
Keyword(s):
2006 ◽
Vol 22
(9)
◽
pp. 1799-1805
◽
Keyword(s):
2008 ◽
Vol 86
(8)
◽
pp. 860-865
◽
Keyword(s):